In the fast-paced biotech and pharma landscape, Weave’s AI-native platform simplifies regulatory workflows, from document creation to submission, tackling the industry’s biggest challenges. By providing a single source of truth, Weave fosters seamless collaboration, ensures compliance, and accelerates therapeutic development timelines. Streamlining processes and creating a living record of therapeutic candidates, Weave empowers teams to focus on strategic decisions with confidence and clarity.

Regulatory submissions are no longer written—they’re built. The science of drug discovery and development today is breathtaking: genomics, proteomics, metabolomics, high-throughput screening, AI protein modeling, single-cell sequencing, gene and cell therapies. Yet all that complexity is funneled through outdated processes. Surely there’s a better way to distill a drug’s story for health authorities.

Now there is. With the power of AI, regulatory submissions can be generated and constructed, not just written. What does that mean? You push a button to get a draft. Key details missing? Need a different narrative structure or a reduced level of detail? Just ask the AI. When you're ready, every sentence's source is one click away. Want a table to summarize these studies? Just ask for it.

Spend your time thinking, interpreting, experimenting, and strategizing instead of typing. Try different narratives to find the most compelling one, each at the push of a button. You can build a house with a hammer, but a nail gun makes it faster. The Weave AI-native Platform lets you leverage your knowledge and experience to do more and go further, delivering better medicines to patients, faster.